We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Another Mutation Found for Rare Skeletal Disorder

By Biotechdaily staff writers
Posted on 29 Aug 2003
Researchers studying the rare inherited skeletal disorder mandibuloacral dysplasia (MAD) have found a mutation in the ZMPSTE24 gene in a patient suffering from the syndrome but lacking the mutation in the LMNA gene that usually characterizes the disorder.

MAD is a rare, genetically and phenotypically heterogeneous, autosomal recessive disorder characterized by skeletal abnormalities. More...
Previous studies had shown that a mutation in the LMNA gene, which encodes the proteins lamin A and lamin C, components of the membrane of the cell nucleus, was linked to the development of the syndrome. In the current study, which was published in the August 15, 2003, issue of Human Molecular Genetics, investigators at the University of Texas Southwestern Medical Center (Dallas, USA) focused their attention on a mutation in the ZMPSTEA24 gene that they found in a MAD patient who lacked the LMNA mutation.

They found that ZMPSTEA24 produced a zinc metalloproteinase enzyme that played a critical role in the synthesis of active lamin A. Senior author Dr. Abhimanyu Garg, professor of internal medicine at the University of Texas Southwestern Medical Center explained, "It was known that a mutation in LMNA caused MAD, but in several of the individuals that we studied LMNA was normal. This led us to look at other genes that were associated with lamin A production. We considered ZMPSTE24 as a candidate gene based on recent reports that deletion of this gene in mice resulted in the development of similar physical features of the human form of MAD.”




Related Links:
Univ. of Texas Southwestern Medical Center

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Clinical Informatics Platform
CLARION™
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.